Anthrax Lethal Factor Protease Inhibitors:  Synthesis, SAR, and Structure-Based 3D QSAR Studies

Sherida L. Johnson, Dawoon Jung, Martino Forino, Ya Chen, Arnold Satterthwait, Dmitry V. Rozanov, Alex Y. Strongin, and Maurizio Pellecchia*
Cancer Research Center and Infectious and Inflammatory Disease Center, Burnham Institute for Medical Research, 10901 North Torrey Pines Road, La Jolla, California 92037
J. Med. Chem., 2006, 49 (1), pp 27–30
DOI: 10.1021/jm050892j
Publication Date (Web): December 1, 2005
Copyright © 2006 American Chemical Society

 These authors contributed equally to this work.

,

 Present address:  Dipartimento di Chimica delle Sostanze Naturali, Facoltà di Farmacia, Università degli Studi “Federico II” di Napoli, Italy.

,
*

 To whom correspondence should be addressed. Tel:  (858) 646-3159. Fax:  (858) 713-9925. E-mail:  mpellecchia@burnham.org.

Abstract

Abstract Image

We have recently identified a series of compounds that efficiently inhibit anthrax lethal factor (LF) metallo-protease. Here we present further structure−activity relationship and CoMFA (comparative molecular field analysis) studies on newly derived inhibitors. The obtained 3D QSAR model was subsequently compared with the X-ray structure of the complex between LF and a representative compound. Our studies form the basis for the rational design of additional compounds with improved activity and selectivity.

Tools

Accession Codes

History

  • Published In Issue January 12, 2006
  • Received September 9, 2005

Recommend & Share

Related Content

Other ACS content by these authors: